RAPID PATHOGEN SCREENING
Founded in 2004, Rapid Pathogen Screening, Inc. (RPS®) is an emerging developer, manufacturer, and marketer of rapid point-of-care (POC) diagnostic tests. The company’s innovative and patented technology platform facilitates the development of a spectrum of cost-effective tests to rapidly identify patients with infectious diseases and inflammatory conditions. As a result of U.S. government contracts, this platform is also being used to develop tests for bio-terrorism and chemical nerve agent blood toxins. RPS tests have high sensitivity and specificity, and can be easily performed by a clinician or their staff without extensive training or additional equipment. For more information on RPS or its products, visit RPSdetectors.com.
RAPID PATHOGEN SCREENING
Social Links:
Industry:
Biotechnology Manufacturing Medical
Founded:
2004-01-01
Address:
Sarasota, Florida, United States
Country:
United States
Website Url:
http://www.RPSdetectors.com
Total Employee:
11+
Status:
Active
Contact:
(194) 155-6185
Email Addresses:
[email protected]
Total Funding:
56.04 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS Cloudflare Hosting Cloudflare DNS Gravity Forms Barracuda Networks
Similar Organizations
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
Current Employees Featured
Founder
Investors List
OrbiMed
OrbiMed investment in Debt Financing - Rapid Pathogen Screening
